Projects
Enhancing Type 2 Diabetes Care by an Individualized and Group-Based Therapeutic Patient Education Program
Cluster randomized controlled trial evaluating an interdisciplinary type 2 diabetes (T2D) management program combining therapeutic patient education (TPE), individualized care plans, group-based quality circles, and regular PROM collection and feedback. The study aims to improve clinical outcomes, health-related quality of life, patient experience, self-management behaviors, and assess cost-effectiveness compared with standard care.
Organisation
Organisation: Réseau Delta (Geneva, Switzerland), in collaboration with the University of St. Gallen School of Medicine, Groupe Mutuel Services AG, and SOKLE.
Date
August 14, 2026
Conditions covered
Conditions covered: Type 2 Diabetes (T2D), Chronic disease management, Diabetes self-management and patient education, Health-related quality of life, Psychological well-being and diabetes-related distress
Tools used
Status
Status: Ongoing clinical study (Cluster Randomized Controlled Trial). Recruitment started in 2025 and the study is expected to run until September 2026.
Type: Studies or Conceptual Work
Contact
Dr. Philippe Schaller, MD (Principal Investigator / Trial Sponsor)
